{"database": "lobbying", "table": "lobbying_activities", "rows": [[1439053, "b6a474f2-50c7-40de-b5aa-797e3d39a188", "Q3", "ROCK & ASSOCIATES", 33545, "WEDGEWOOD VILLAGE PHARMACY, INC.", 2013, "third_quarter", "LAW", "Proposals to amend the Controlled Substances Act to clarify the definition of  \"dispense\" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.", "HOUSE OF REPRESENTATIVES,SENATE", 11200, null, 0, 0, "2013-10-08T16:47:28.187000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1439053"], "units": {}, "query_ms": 44.61429000366479, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}